Brain Behavior and Immunity, Год журнала: 2024, Номер unknown
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
9Neurobiology of Disease, Год журнала: 2024, Номер 199, С. 106573 - 106573
Опубликована: Июнь 18, 2024
Arketamine, the (R)-enantiomer of ketamine, exhibits antidepressant-like effects in mice, though precise molecular mechanisms remain elusive. It has been shown to reduce splenomegaly and depression-like behaviors chronic social defeat stress (CSDS) model depression. This study investigated whether spleen contributes arketamine CSDS model. We found that splenectomy significantly inhibited arketamine's CSDS-susceptible mice. RNA-sequencing analysis identified oxidative phosphorylation (OXPHOS) pathway prefrontal cortex (PFC) as a key mediator splenectomy's impact on effects. Furthermore, oligomycin A, an inhibitor OXPHOS pathway, reversed suppressive Specific genes within pathways, such COX11, UQCR11 ATP5e, may contribute these inhibitory Notably, transforming growth factor (TGF)-β1, along with appears modulate Additionally, SRI-01138, agonist TGF-β1 receptor, alleviated Subdiaphragmatic vagotomy also counteracted These findings suggest PFC play significant roles arketamine, mediated through spleen-brain axis via vagus nerve.
Язык: Английский
Процитировано
7Neurobiology of Disease, Год журнала: 2024, Номер 199, С. 106570 - 106570
Опубликована: Июнь 15, 2024
Hepatic lipoprotein receptor-related protein 1 (LRP-1) plays a central role in peripheral amyloid beta (Aβ) clearance, but its importance Alzheimer's disease (AD) pathology is understudied. Our previous work showed that intragastric alcohol feeding to C57BL/6 J mice reduced hepatic LRP-1 expression which correlated with significant AD-relevant brain changes. Herein, we examined the of AD pathogenesis APP/PS1 using two approaches modulate LRP-1, model chronic heavy drinking shown by us reduce and hepato-specific silencing.
Язык: Английский
Процитировано
5Advanced Biology, Год журнала: 2025, Номер unknown
Опубликована: Апрель 8, 2025
Abstract Exercise training can prevent anxiety disorders in both rodent models and human cohorts. The involvement of peripheral factors exercise‐mediated mental health is being appreciated. It recently shown that the hepatic biosynthesis lipocalin‐2 (LCN2) respond to chronic restraint stress (CRS) elicit anxiety‐like behaviors via inhibiting neural activity medial prefrontal cortex (mPFC). Here, it found 14‐day treadmill exercise ameliorates these CRS‐treated mice. Further assays show intervention reduces release LCN2. Meanwhile, may also counteract adverse effect LCN2 relieving cortical microglial cell proliferation. results collectively suggest modulate liver‐brain axis reshape for preventing disorders.
Язык: Английский
Процитировано
0Neurobiology of Disease, Год журнала: 2024, Номер unknown, С. 106666 - 106666
Опубликована: Сен. 1, 2024
Язык: Английский
Процитировано
2Journal of Affective Disorders, Год журнала: 2024, Номер 362, С. 114 - 125
Опубликована: Июнь 27, 2024
Язык: Английский
Процитировано
2Journal of Neuropsychiatry, Год журнала: 2024, Номер 36(4), С. 278 - 282
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
2Brain and Behavior, Год журнала: 2024, Номер 14(8)
Опубликована: Авг. 1, 2024
Depressive symptoms are frequently observed in patients with primary biliary cholangitis (PBC). The role of depressive on cirrhosis has not been fully noticed PBC. We aimed to establish a risk model for that took into account.
Язык: Английский
Процитировано
1Advances in pharmacology, Год журнала: 2024, Номер unknown, С. 237 - 266
Опубликована: Окт. 16, 2024
Язык: Английский
Процитировано
1AJP Gastrointestinal and Liver Physiology, Год журнала: 2024, Номер 327(6), С. G850 - G860
Опубликована: Окт. 29, 2024
This study explores how exercise affects liver fibrosis-related anxiety in mice. Researchers found that regular reversed carbon tetrachloride (CCl 4 )-induced fibrosis and reduced anxiety, even mice with fibrosis. Exercise increased brain-derived neurotrophic factor (BDNF) decreased neuronal nitric oxide synthase (nNOS) the hippocampus. These findings suggest has therapeutic potential for treating associated chronic disease by modulating specific brain factors.
Язык: Английский
Процитировано
1